Neuropacs is an AI-based software platform, specializes in neurodegenerative diseases.
Neuropacs has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in January 2026.
Neuropacs's investors include Neuro Investment Group.
Neuropacs is headquartered in Gainesville, United States.
Neuropacs is an AI-based software platform, specializes in neurodegenerative diseases.
Neuropacs is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuropacs — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/neuropacs. Accessed August 15, 2026.
VCBacked. (2026). Neuropacs — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/neuropacs
{{cite web |title=Neuropacs — Funding & Investors |url=https://www.vcbacked.co/company/neuropacs |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated